GLOW Study: Effects of Triple Protein in Women
GLOW Study: A Randomized Trial to Evaluate the Effects of Triple Support Protein on Glucose, Lifestyle, and Overall Well-being in Women
University of North Carolina, Chapel Hill
40 participants
Apr 1, 2026
INTERVENTIONAL
Conditions
Summary
This single-site, randomized, blinded, placebo-controlled study will evaluate whether 4 weeks of daily Triple Support Protein powder improves glycemic control and overall well-being in healthy women aged 30-60 years. Participants will undergo baseline testing (DXA, fasting blood, standardized meal test with 2-hour glucose and insulin sampling), complete one acute supervised dose, and then consume a daily supplement for 4 weeks. During the final 14 days, participants will wear a continuous glucose monitor. Outcomes include postprandial glucose AUC, insulin sensitivity, and body composition.
Eligibility
Inclusion Criteria5
- Females aged 30-60 years.
- BMI 18.5-40 kg/m\^2.
- Recreationally active (≥30 min/wk moderate intensity exercise).
- Healthy and free from disease per health history questionnaire.
- Willing to abstain from caffeine, tobacco, and alcohol for 24 hours before testing days.
Exclusion Criteria5
- Currently supplementing whey protein.
- Pregnant or nursing.
- Lactose intolerant.
- Currently using creatine monohydrate.
- Severe hearing or speech impairment or inability to speak English
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Plant based protein + creatine + fiber
Non-caloric matched placebo
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07526571